trending Market Intelligence /marketintelligence/en/news-insights/trending/roqrwyuwdflihokjx4wv4a2 content esgSubNav
In This List

Aileron Therapeutics appoints chairman

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Aileron Therapeutics appoints chairman

Aileron Therapeutics, Inc. appointed Jeffrey Bailey as chairman of its board of directors.

Bailey serves as CEO and director of privately held device maker IlluminOss Medical, Inc.

He is also a director at Madison Vaccines, Inc.

Bailey replaces Scott Kapnick as chairman of the Cambridge, Mass.-based biotechnology company. Kapnick will remain on the company's board.

In addition, Aileron said Brian Gallagher Jr. resigned from the company's board.